Navigation Links
OFS to Present Paper on Effects of High Humidity and High Temperature on Optical Fiber for High-Power Delivery
Date:1/19/2012

AVON, Conn., Jan. 19, 2012 /PRNewswire/ -- The Specialty Photonics Division of OFS Fitel, LLC (OFS SPD), a leading provider of optical fiber, cable, and assemblies for medical device manufacturers, announces that Dr. Lei Huang will present "Effects of high humidity and high temperature on failure of optical fiber for high-power delivery" at the upcoming BiOS Technology Conference.  Dr. Huang will present on Saturday, January 21st at 2:20PM, in room 238 (Mezzanine)

(Logo:  http://photos.prnewswire.com/prnh/20120119/CL38819LOGO )

Large core silica optical fibers are often used for delivering high power laser for medical applications.  It has been observed that optical fibers that are transmitting high power laser light may fracture when bent and that the polymer cladding or coating of the fiber plays a significant part in determining the fiber strength.  Dr. Huang's presentation will examine the fiber performance in bending under high laser power after the fiber has been autoclaved — subjecting the fiber to high humidity and high temperature — a common method of sterilization.

OFS SPD will exhibit and showcase its line of optical fiber, cable, and assemblies for the medical market at the BiOS Tradeshow, January 21st–22nd.

About OFS

OFS is a world-leading designer, manufacturer and provider of optical fiber, optical fiber cable, FTTX, optical connectivity and specialty photonics products. Our manufacturing and research divisions work together to provide innovative products and solutions that traverse many different applications as they link people and machines worldwide. Between continents, between cities, around neighborhoods, and into homes and businesses of digital consumers we provide the right optical fiber, optical cable and components for efficient, cost-effective transmission.

OFS' corporate lineage dates back to 1876 and includes technology powerhouses such as AT&T and Lucent Technologies (now Alcatel-Lucent). Today, OFS is owned by Furukawa Electric, a multi-billion dollar global leader in optical communications. 

Headquartered in Norcross (near Atlanta) Georgia, U.S., OFS is a global provider with facilities in Avon, Connecticut; Carrollton, Georgia; Somerset, New Jersey; and Sturbridge, Massachusetts, as well as in Denmark, Germany and Russia. For more information, please visit www.ofsoptics.com.

About OFS, Specialty Photonics Division

OFS, Specialty Photonics Division, is an industry leader in optical fiber design or modification for highly specialized or customized applications. It supplies advanced optical fibers, including specialty multimode, specialty single-mode, rare-earth doped, polarization-maintaining and other nonstandard fibers. It also manufactures specialty cables and connectors, and other specialty products, such as high-power laser components. For more information about the Specialty Photonics Division, please visit: www.SpecialtyPhotonics.com

 

 


'/>"/>
SOURCE OFS, Specialty Photonics Division
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology:
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):